Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
Nortech Systems Inc Market Cap
Based on ratings from 0 stock analysts, the Nortech Systems Inc stock price is expected to decrease by 100% in 12 months. This is calculated by using the average 12-month stock price forecast for Nortech Systems Inc. The lowest target is $ and the highest is $. Please note analyst price targets are not guaranteed and could be missed completely.
Nortech Systems Inc has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating, the expectation is that Nortech Systems Inc will perform worse than the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of NSYS.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
Data Not Found! | ||||
When did it IPO
1993
Staff Count
733
Country
United States
Sector/Industry
Healthcare/Medical Devices
CEO
Mr. Jay Dean Miller
Market Cap
$33.1M
In 2023, NSYS generated $139.3M in revenue, which was a increase of 3.88% from the previous year. This can be seen as a signal that NSYS's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Sat, 09 Nov 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - Nortech Systems (NASDAQ:NSYS) will hold its Q3 2024 earnings conference call on November 7, 2024, at 8:30 AM ET, featuring CEO Jay Miller and CFO Andrew LaFrence.
Why It Matters - The earnings conference call provides insights into Nortech's financial performance and future guidance, which can impact stock valuations and investor sentiment.
Thu, 07 Nov 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Nortech Systems (Nasdaq: NSYS) reported Q3 financial results for the period ending September 30, 2024, focusing on engineering and manufacturing solutions in medical, industrial, and defense sectors.
Why It Matters - Nortech's Q3 financial results impact its stock performance, reflecting operational health and market demand in key sectors, which can influence investor sentiment and future valuations.
Thu, 24 Oct 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Nortech Systems (Nasdaq: NSYS) will host a conference call on November 7, 2024, at 7:30 a.m. CT to discuss Q3 financial results. Access via phone or webcast.
Why It Matters - Nortech Systems' upcoming conference call will reveal Q3 financial results, impacting stock valuation and investor sentiment in the medical and aerospace sectors.
Tue, 08 Oct 2024
Sentiment - NEUTRAL
Source - Business Wire
Summary - Nortech Systems (Nasdaq: NSYS) has certified trainers and operators to produce PCBAs to the IPC-J-STD-001 Space Addendum standard, enhancing its manufacturing capabilities in aerospace and defense.
Why It Matters - Certification to the IPC-J-STD-001 Space Addendum standard boosts Nortech Systems' production capabilities, potentially increasing demand in the aerospace and defense sectors, impacting revenue growth.
Sat, 10 Aug 2024
Sentiment - NEUTRAL
Source - Seeking Alpha
Summary - Nortech Systems (NASDAQ:NSYS) will hold its Q2 2024 earnings conference call on August 8, 2024, at 8:30 AM ET, featuring CEO Jay Miller and CFO Andrew LaFrence.
Why It Matters - Nortech Systems' Q2 2024 earnings call indicates potential financial performance insights, operational updates, and strategic direction, which can impact stock valuation and investor sentiment.
Thu, 08 Aug 2024
Sentiment - NEUTRAL
Source - GlobeNewsWire
Summary - Nortech Systems Inc. (Nasdaq: NSYS) reported its second-quarter financial results for the period ending June 30, 2024. The company provides engineering and manufacturing solutions for various markets.
Why It Matters - Nortech's Q2 financial results indicate its performance and growth trajectory in key sectors, impacting stock valuation and investor sentiment in the medical and defense markets.
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
